Celularity Inc. (CELU)
NASDAQ: CELU · Real-Time Price · USD
2.230
+0.080 (3.72%)
Sep 17, 2025, 12:52 PM EDT - Market open

Celularity Statistics

Total Valuation

Celularity has a market cap or net worth of $59.52 million. The enterprise value is $126.68 million.

Market Cap59.52M
Enterprise Value 126.68M

Important Dates

The last earnings date was Friday, August 29, 2025, after market close.

Earnings Date Aug 29, 2025
Ex-Dividend Date n/a

Share Statistics

Celularity has 26.69 million shares outstanding. The number of shares has increased by 12.89% in one year.

Current Share Class 26.69M
Shares Outstanding 26.69M
Shares Change (YoY) +12.89%
Shares Change (QoQ) +2.08%
Owned by Insiders (%) 12.14%
Owned by Institutions (%) 13.14%
Float 13.70M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 1.11
Forward PS n/a
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 2.84
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.25

Current Ratio 0.25
Quick Ratio 0.17
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -5.96

Financial Efficiency

Return on equity (ROE) is -6,367.24% and return on invested capital (ROIC) is -42.33%.

Return on Equity (ROE) -6,367.24%
Return on Assets (ROA) -23.14%
Return on Invested Capital (ROIC) -42.33%
Return on Capital Employed (ROCE) -92.74%
Revenue Per Employee $362,520
Profits Per Employee -$598,935
Employee Count123
Asset Turnover 0.35
Inventory Turnover 5.47

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -22.58% in the last 52 weeks. The beta is 0.81, so Celularity's price volatility has been lower than the market average.

Beta (5Y) 0.81
52-Week Price Change -22.58%
50-Day Moving Average 3.00
200-Day Moving Average 2.19
Relative Strength Index (RSI) 34.91
Average Volume (20 Days) 136,236

Short Selling Information

The latest short interest is 1.69 million, so 6.33% of the outstanding shares have been sold short.

Short Interest 1.69M
Short Previous Month 1.63M
Short % of Shares Out 6.33%
Short % of Float 12.32%
Short Ratio (days to cover) 24.22

Income Statement

In the last 12 months, Celularity had revenue of $44.59 million and -$73.67 million in losses. Loss per share was -$3.21.

Revenue44.59M
Gross Profit 24.57M
Operating Income -47.35M
Pretax Income -196.29M
Net Income -73.67M
EBITDA -39.91M
EBIT -47.35M
Loss Per Share -$3.21
Full Income Statement

Balance Sheet

The company has $863,000 in cash and $70.15 million in debt, giving a net cash position of -$69.29 million or -$2.60 per share.

Cash & Cash Equivalents 863,000
Total Debt 70.15M
Net Cash -69.29M
Net Cash Per Share -$2.60
Equity (Book Value) -25.50M
Book Value Per Share -1.04
Working Capital -51.96M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$2.54 million and capital expenditures -$91,000, giving a free cash flow of -$2.63 million.

Operating Cash Flow -2.54M
Capital Expenditures -91,000
Free Cash Flow -2.63M
FCF Per Share -$0.10
Full Cash Flow Statement

Margins

Gross margin is 55.10%, with operating and profit margins of -106.19% and -165.21%.

Gross Margin 55.10%
Operating Margin -106.19%
Pretax Margin -165.21%
Profit Margin -165.21%
EBITDA Margin -89.51%
EBIT Margin -106.19%
FCF Margin n/a

Dividends & Yields

Celularity does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -12.89%
Shareholder Yield -12.89%
Earnings Yield -128.37%
FCF Yield -4.59%

Analyst Forecast

The average price target for Celularity is $6.00, which is 169.06% higher than the current price. The consensus rating is "Strong Buy".

Price Target $6.00
Price Target Difference 169.06%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on February 29, 2024. It was a reverse split with a ratio of 1:10.

Last Split Date Feb 29, 2024
Split Type Reverse
Split Ratio 1:10

Scores

Celularity has an Altman Z-Score of -12.23 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -12.23
Piotroski F-Score 2